Ardelyx (ARDX) Shares Outstanding (2013 - 2026)

Ardelyx's (ARDX) quarterly Shares Outstanding (Entity) came in at $247.0 million in Q1 2026, up 3.25% YoY from $239.2 million in Q1 2025, and up 1.07% on a QoQ basis from $244.4 million in Q4 2025.

Ardelyx (ARDX) Shares Outstanding (2013 - 2026) Analysis & Trends

Ardelyx (ARDX) has 14 years of Shares Outstanding (Entity) data on file, last reported at $247.0 million in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 3.25% year-over-year to $247.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $247.0 million (up 3.25% YoY) and the FY2025 annual result came in at $244.4 million, up 2.66% from the prior year.
  • Shares Outstanding (Entity) climbed to $247.0 million in Q1 2026, from $244.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $247.0 million in Q1 2026 to a low of $136.3 million in Q1 2022.
  • A 5-year average of $217.2 million and a median of $234.0 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) soared 75.51% — and 2024, when it grew 2.05%.
  • Tracing ARDX's Shares Outstanding (Entity) over 5 years: stood at $158.7 million in 2022, then surged by 46.48% to $232.5 million in 2023, then advanced by 2.39% to $238.0 million in 2024, then increased by 2.66% to $244.4 million in 2025, then rose by 1.07% to $247.0 million in 2026.
  • The last three Shares Outstanding (Entity) figures came in at $247.0 million (Q1 2026), $244.4 million (Q4 2025), and $243.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.19 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.45 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 445.06 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.61 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Ardelyx 1.01 Bn 729.71 Mn 115.12 Mn 248.07 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 248.07 Mn
Mar 31, 2026 245.86 Mn
Dec 31, 2025 241.03 Mn
Sep 30, 2025 241.91 Mn
Jun 30, 2025 239.93 Mn
Mar 31, 2025 238.62 Mn
Dec 31, 2024 235.23 Mn
Sep 30, 2024 235.91 Mn
Jun 30, 2024 234.57 Mn
Mar 31, 2024 233.07 Mn
Dec 31, 2023 219.33 Mn
Sep 30, 2023 222.78 Mn
Jun 30, 2023 214.95 Mn
Mar 31, 2023 207.02 Mn
Dec 31, 2022 158.69 Mn
Sep 30, 2022 165.11 Mn
Jun 30, 2022 145.54 Mn
Mar 31, 2022 130.94 Mn
Dec 31, 2021 104.21 Mn
Sep 30, 2021 104.15 Mn